
BioSig Technologies BSGM
Quarterly report 2025-Q3
added 11-14-2025
BioSig Technologies General and Administrative Expenses 2011-2026 | BSGM
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses BioSig Technologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.6 M | 23.1 M | 21.4 M | 27.9 M | 41 M | 24.8 M | 12.9 M | 8.14 M | 8.5 M | 10.8 M | 7.3 M | 5.23 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 41 M | 5.23 M | 16.9 M |
Quarterly General and Administrative Expenses BioSig Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.62 M | 19.8 M | 2.96 M | - | 2.76 M | 4.91 M | 2.88 M | - | 2.82 M | 9.11 M | 6.24 M | - | 4.77 M | 4.3 M | 6.4 M | - | 6.5 M | 6.48 M | 7.27 M | - | 8.16 M | 16.6 M | 7.86 M | - | 3.84 M | 6.16 M | 4.38 M | - | 2.41 M | 4.31 M | 1.77 M | - | 787 K | 1.68 M | 1.56 M | - | 992 K | 4.38 M | 1.94 M | - | 2.12 M | 3.94 M | 2.75 M | - | 3.8 M | 485 K | 602 K | - | 509 K | 1.04 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 19.8 M | 485 K | 4.58 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | - | - | $ 1.77 B | ||
|
Insulet Corporation
PODD
|
1.16 B | $ 216.0 | -4.21 % | $ 15.2 B | ||
|
Axonics Modulation Technologies
AXNX
|
40.2 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
15.1 M | - | 1.37 % | $ 20.5 M | ||
|
Profound Medical Corp.
PROF
|
10.3 M | $ 5.82 | 13.01 % | $ 180 M | ||
|
Acutus Medical
AFIB
|
14.1 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
7.11 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
8.78 M | - | -5.86 % | $ 30.6 M | ||
|
Second Sight Medical Products
EYES
|
806 K | - | -0.97 % | $ 54.4 M | ||
|
Quanterix Corporation
QTRX
|
138 M | $ 3.96 | 3.66 % | $ 169 M | ||
|
AVITA Medical
RCEL
|
27.4 M | $ 3.99 | 3.91 % | $ 111 M | ||
|
Conformis
CFMS
|
28.8 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
171 M | - | 0.15 % | $ 844 M | ||
|
IRIDEX Corporation
IRIX
|
8.75 M | $ 1.33 | -1.85 % | $ 21.5 M | ||
|
Apollo Endosurgery
APEN
|
20.6 M | - | - | $ 475 M | ||
|
IRadimed Corporation
IRMD
|
17.8 M | $ 101.78 | 0.8 % | $ 1.29 B | ||
|
Avinger
AVGR
|
14.1 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
141 M | - | -4.14 % | $ 702 M | ||
|
Sintx Technologies
SINT
|
6.2 M | $ 2.56 | -0.39 % | $ 7.1 M | ||
|
CONMED Corporation
CNMD
|
132 M | $ 37.08 | 1.42 % | $ 1.15 B | ||
|
Smith & Nephew plc
SNN
|
2.72 B | - | - | $ 23.8 B | ||
|
Soliton, Inc.
SOLY
|
8.46 M | - | -1.42 % | $ 435 M | ||
|
Sensus Healthcare
SRTS
|
7.87 M | $ 4.22 | 6.57 % | $ 68.9 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.88 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
8.5 M | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
3.46 M | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
39.3 M | $ 24.66 | -0.16 % | $ 208 M | ||
|
Misonix, Inc.
MSON
|
18 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M | ||
|
Tactile Systems Technology
TCMD
|
88.7 M | $ 26.96 | 0.37 % | $ 617 M | ||
|
TELA Bio
TELA
|
14.9 M | $ 0.69 | -9.35 % | $ 15.8 M | ||
|
Intersect ENT, Inc.
XENT
|
98.6 M | - | - | $ 955 M | ||
|
Tandem Diabetes Care
TNDM
|
445 M | $ 24.26 | -1.02 % | $ 1.65 B | ||
|
Cytosorbents Corporation
CTSO
|
35 M | $ 0.67 | -3.52 % | $ 36.5 M | ||
|
Aethlon Medical
AEMD
|
3.24 M | $ 2.32 | 7.41 % | $ 3.62 M | ||
|
BIOLASE
BIOL
|
10.2 M | - | -13.19 % | $ 166 K | ||
|
InspireMD
NSPR
|
20.7 M | $ 1.77 | -1.12 % | $ 114 M | ||
|
AdaptHealth Corp.
AHCO
|
382 M | $ 11.39 | -0.78 % | $ 1.54 B | ||
|
Penumbra
PEN
|
663 M | $ 336.27 | 0.63 % | $ 13.1 B | ||
|
Myomo
MYO
|
14 M | $ 0.7 | -0.1 % | $ 29.3 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
22.5 M | $ 2.29 | -4.58 % | $ 134 M | ||
|
Invacare Corporation
IVC
|
227 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
5.9 M | $ 3.71 | -5.12 % | $ 138 M | ||
|
OrthoPediatrics Corp.
KIDS
|
120 M | $ 16.23 | 2.01 % | $ 381 M | ||
|
Outset Medical
OM
|
37.9 M | $ 3.53 | - | $ 53.7 K | ||
|
Inspire Medical Systems
INSP
|
625 M | $ 51.41 | -1.27 % | $ 1.51 B | ||
|
Varex Imaging Corporation
VREX
|
133 M | $ 10.69 | 0.66 % | $ 443 M |